KARD vs SNDX: stock comparison and AI forecast
Kardigan, Inc. (KARD) and Syndax Pharmaceuticals Inc (SNDX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
KARD Kardigan, Inc.
- Price
- $13.86 -37.2% · 6M
- Market Cap
- $1.30B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
SNDX Syndax Pharmaceuticals Inc
- Price
- $10.45 -49.4% · 6M
- Market Cap
- $837M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- KARD is 1.5 times larger than SNDX by market capitalization ($1.30B against $837M).
- Over the last six months KARD returned -37.2% and SNDX -49.4%.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | KARD | SNDX |
|---|---|---|
| Market Cap | $1.30B | $837M |
| P/B Ratio | 2.11x | – |
| EPS | – | $-3.35 |
| Book Value/Share | $6.58 | – |
| Revenue/Share | – | $3.89 |
Profitability & Margins
| Metric | KARD | SNDX |
|---|---|---|
| ROA | – | -30.2% |
| ROIC | – | -31.2% |
| Operating Margin | – | -51.4% |
| Net Margin | – | -60.3% |
| EBT Margin | – | -51.4% |
| Tax Rate | – | -0.2% |
Financial Health
| Metric | KARD | SNDX |
|---|---|---|
| Current Ratio | 8.72x | 4.69x |
| Quick Ratio | – | 4.37x |
| D/E Ratio | 0.17x | – |
| Financial Leverage | 1.17x | – |
| Interest Coverage | – | 963.6x |
| Working Capital | $540M | $446M |
Cash Flow
| Metric | KARD | SNDX |
|---|---|---|
| Operating Cash Flow | – | -$177M |
Operational Efficiency
| Metric | KARD | SNDX |
|---|---|---|
| Asset Turnover | – | 0.50x |
| Fixed Assets Turnover | – | 1686.6x |
Income Statement
| Metric | KARD | SNDX |
|---|---|---|
| Total Revenue | – | $347M |
| Operating Income | – | -$179M |
| Net Income | – | -$209M |
| R&D Expense | – | $273M |
Dividend & Shareholder Information
| Metric | KARD | SNDX |
|---|---|---|
| Shares Outstanding | 94M | 89M |
KARD vs SNDX: stock comparison and AI forecast
Which is bigger, KARD or SNDX?
KARD is 1.5 times larger than SNDX by market capitalization ($1.30B against $837M).
Which stock performed better over the last six months, KARD or SNDX?
Over the last six months KARD returned -37.2% and SNDX -49.4%.
Which one does Intratio's AI model rank higher, KARD or SNDX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.